Home/ Supplements/ Feverfew/ Feverfew

Feverfew

product on market Liquid Hawaii Pharm Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Feverfew
Open Full PDF View on NIH DSLD →
Details

Label Data

0.7 mL
Serving Size
120
Servings
Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 380.0mg (120 products) 8 studies — no high-quality reviews

Other Ingredients

Vegetable Palm Glycerin pharmaceutical grade Alcohol artesian Hawaiian purified Water
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions for use: Shake well before using. Take about 20-30 drops (0.7-1 ml, one full squeeze of the dropper bulb) to 2-4 oz of juice or water up to 4 times per day.

Warnings & Precautions

Warning: Keep out of the reach of children.

May have contraindications. We recommend to seek expert medical advice before taking.

Do not use if you are allergic to any ingredients.

Consult a physician before using during pregnancy, if nursing or taking any medications.

Do not use if seal is broken or missing.

Formulation Notes

Contains no GMO, gluten, artificial colors, heavy metals, preservatives, pesticides, fertilizers.

(Tanacetum parthenium)

Super concentrated liquid herbal extract. Dry herb/menstruum ratio: 1:3.

Manufactured in an FDA registered facility.

Non GMO Gluten free

Made in USA, Hawaii

Additional Information

Hawaii Pharm Herbal Extract Highest quality since 2008

Store in a cool dry place.

Made with Aloha!

FDA Registered Facility Made in United States of America USA

Metadata

Product Details

UPC / SKU6 50905 45719 7
DSLD Entry Date2020-10-23
Product TypeBotanical
FormLiquid
DSLD ID237843
Data Updated2026-04-11
Research

Research Evidence

10
Research Sources
48
Avg Quality
4
Systematic Review
4
Rct
1
Meta Analysis
1
Cochrane Review
B Feverfew for preventing migraine.
Cochrane Review The Cochrane database of systematic reviews PubMed
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2004 PubMed
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2000 PubMed
C Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
Rct Lancet (London, England) 1988 PubMed
C Feverfew for migraine prophylaxis: a systematic review
Systematic Review Journal of dietary supplements 2009 PubMed DOI
C Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study
Meta Analysis Clinical drug investigation 2006 PubMed
C The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study
Rct Acupuncture in medicine : journal of the British Medical Acupuncture Society 2012 PubMed DOI
C A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial
Rct Headache 2004 PubMed
C Feverfew as a preventive treatment for migraine: a systematic review
Systematic Review Cephalalgia : an international journal of headache 1998 PubMed
D Efficacy of feverfew as prophylactic treatment of migraine
Rct British medical journal (Clinical research ed.) 1985 PubMed
View all evidence for Feverfew →
Compare

Similar Products

View all Feverfew products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.